Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study
Both monthly and quarterly regimens were effective and safe, with a tendency for an advantage of the monthly regimen only in the first quarter of treatment.
Authors
- Massimo Filippi (ORCID: https://orcid.org/0000-0002-5485-0479)
- Roberta Messina (ORCID: https://orcid.org/0000-0003-4421-0432)
- Sabina Cevoli (ORCID: https://orcid.org/0000-0003-4668-4295)
- Federica Genovese (ORCID: https://orcid.org/0000-0003-1984-1881)
- Simone Guerrieri (ORCID: https://orcid.org/0000-0002-8819-828X)
- Laura Zanandrea
- Ilaria Cetta (ORCID: https://orcid.org/0000-0002-9493-3885)
- Valentina Favoni (ORCID: https://orcid.org/0000-0001-5335-2438)
- Claudia Altamura (ORCID: https://orcid.org/0000-0002-5934-5535)
- Fabrizio Vernieri (ORCID: https://orcid.org/0000-0002-9594-9336)
- Bruno Colombo
Institutions
- Vita-Salute San Raffaele University (IT)
- Università Campus Bio-Medico (IT)
- Istituto delle Scienze Neurologiche di Bologna (IT)
- Campus Bio Medico University Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1111/ene.16410
- Citations
- 4
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.54